Patient- Specific Custom Reconstruction Strategies and Implants

Disclosure(s):

Matthew Goodwin, MD: AO Spine: Board Member/Officer/Trustee (Ongoing); BioNTech: Stock Shareholder (excluding mutual funds) (Ongoing); Johnson & Johnson: Stock Shareholder (excluding mutual funds) (Ongoing); KAIA: Research Grant (Ongoing); Kendall Hunt Publishing: Royalty Recipient (Ongoing); Merck: Stock Shareholder (excluding mutual funds) (Ongoing); Moderna: Stock Shareholder (excluding mutual funds) (Ongoing); NASS: Board Member/Officer/Trustee (Ongoing); Pfizer: Stock Shareholder (excluding mutual funds) (Ongoing); ROM3: Stock Shareholder (excluding mutual funds) (Ongoing)